Sodium-glucose co-transporters (SGLTs) are membrane proteins that facilitate the reabsorption of glucose in the kidneys by coupling glucose transport with sodium ions. SGLT inhibitors are an important class of drugs used in the treatment of type 2 diabetes, as they help reduce blood glucose levels by preventing glucose reabsorption in the renal tubules. These inhibitors are also being investigated for their potential benefits in cardiovascular and renal protection. At CymitQuimica, we provide a range of high-quality SGLT modulators to support your research in diabetes, renal physiology, and metabolic disorders.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.